Cardiac hematemesis is most commonly seen in acute left heart failure, pulmonary heart disease, and pulmonary hypertension, and the exact survival time is related to the time and manner of rescue and the underlying disease. Timely and effective treatment can reduce the severity of the condition, minimize the occurrence of adverse events, and improve cardiac function and quality of survival.
1. The main symptoms of acute left heart failure are dyspnea, sedentary respiration, sputum and pink foamy sputum, and other acute manifestations, and the long-term survival rate is relatively low, and some may even die in a short period of time. The exact survival time is related to the time and manner of rescue and the underlying disease. The goals of treatment are to improve symptoms, stabilize hemodynamic status, maintain vital organ function, and improve prognosis.
2. The main manifestations of pulmonary heart disease are dyspnea, chest pain, and a sense of suffocation, which may be accompanied by severe cough, hemoptysis, and shock. Chronic pulmonary heart disease is often repeated acute exacerbation, most of the prognosis is poor, the death rate is about 10% to 15%, but after active treatment can prolong life and improve the quality of life.
3. Pulmonary hypertension is mainly characterized by dyspnea, chest pain, dizziness or syncope, hemoptysis. Some research data show that the 5-year survival rate is only 20.8%, but the 5-year survival rate of patients receiving targeted drug therapy for pulmonary arterial hypertension is 70.6%.
Heart disease hemoptysis need timely consultation, standardized treatment under the guidance of doctors, timely and reasonable treatment can be appropriate to extend life and improve the quality of life.